arrow
A

Andreas von Deimling

Heidelberg University Hospital
H指数:175
被引数:17.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Author Correction: IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial

作者更正: 新诊断的星形细胞瘤中的IDH1-mutant疫苗: 多中心,单臂,开放标签,人类第一阶段NOA16试验的最终分析

2026-08-030
OAAI
Integrated Clinicopathologic and Multiomic Profiling Reveals MEIS1-Rearranged Sarcoma as a Distinct Entity With 2 Prognostic Subgroups

整合临床病理与多组学分析揭示MEIS1重排肉瘤为具有2个预后亚组的独立实体

2026-08-010
PRE
Distinct molecular subgroups in pediatric and young-onset meningiomas require age-adapted risk stratification

儿童及年轻起病型脑膜瘤存在不同的分子亚群,需采用年龄适应性的风险分层策略

2026-07-140
OAAI
IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trial

IDH1突变疫苗在新诊断星形细胞瘤中的应用:多中心、单臂、开放标签、首次人体1期NOA16试验的最终分析

2026-07-010
OAAI
Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes

Hetairos是一种基于组织学的人工智能模型,用于预测中枢神经系统肿瘤甲基化亚型

2026-06-100
OAAI
DNA methylation-based classification of hematolymphoid neoplasms

基于DNA甲基化的造血淋巴系统肿瘤分类

2026-04-280
OAAI
Spatial single cell transcriptomic analysis informs tumor developmental hierarchy of DICER1 syndrome related sarcoma

空间单细胞转录组分析揭示了DICER1综合征相关肉瘤的肿瘤发育层次结构

2026-03-300
OAAI
Drug screening on tumor organoids exposes therapeutic vulnerabilities of meningiomas to HDAC1/2i panobinostat

肿瘤类器官药物筛选揭示了脑膜瘤对HDAC1/2i panobinostat的疗法易感性

2026-03-040
PRE
Molecular and Clinical Stratification of Astroblastomas: Three distinct Fusion-Defined Groups Informing Risk-Adapted Treatment Strategies

星形细胞瘤的分子和临床分层: 三个不同的融合定义组告知适应风险的治疗策略

2025-12-220
OA
Loss of global DNA hypermethylation is prognostic in IDH-mutant and 1p/19q-codeleted oligodendrogliomas

全球DNA高甲基化丢失是IDH突变型和1p/19q共缺失型少突胶质细胞瘤的预后指标。

2025-11-260
OAAI
Employing nanopore sequencing on FFPE-derived DNA for CNS tumor diagnostics

采用纳米孔测序技术对FFPE来源的DNA进行中枢神经系统肿瘤诊断

2025-11-060
OAAI
Comparison of therapeutic approaches and multimodal molecular profiling in diffuse leptomeningeal glioneural tumor (DLGNT): Results from a European multicenter cohort

弥漫性软脑膜胶质神经肿瘤(DLGNT)的治疗方法与多模态分子分型比较:欧洲多中心队列研究结果

2025-11-010
OAAI
High-resolution proteomic analysis of medulloblastoma clinical samples identifies MYC immunohistochemistry as a powerful outcome predictor outperforming genetic amplification detection

高分辨率蛋白质组学分析对髓母细胞瘤临床样本的研究确定了MYC免疫组化是一种强大的预后预测因子,其预测性能优于基因扩增检测。

2025-11-010
PRE
Hetairos enables AI-based histopathological classification of CNS tumours

Hetairos 实现了基于 AI 的 CNS 肿瘤组织病理学分类

2025-11-010
OAAI
IDH-MUTANT GLIOMAS ARISE FROM GLIAL PROGENITOR CELLS HARBORING THE INITIAL DRIVER MUTATION

IDH-MUTANT胶质瘤起源于携带初始驱动突变的胶质祖细胞

2025-11-010
OAAI
MACHINE LEARNING AND MULTI-OMIC ANALYSIS IDENTIFY A MICROENVIRONMENT-DRIVEN MENINGIOMA RISK CONTINUUM UNDERLYING MOLECULAR CLASSIFICATIONS

机器学习和多组学分析识别出一种由微环境驱动的、与分子分类相关的脑膜瘤风险连续体

2025-11-010
PRE
Meningioma brain-invasion is linked to inflammatory induced tumor-neuronal connectivity

脑膜瘤的脑内浸润与炎症诱导的肿瘤-神经元连接有关

2025-11-010
OAAI
Advancing CNS tumor diagnostics with expanded DNA methylation-based classification

Sill M, Schrimpf D, Patel A, Sturm D, Jäger N, Sievers P, et al. 推进中枢神经系统肿瘤诊断,扩展基于DNA甲基化的分类方法。medRxiv. (2025). doi: 10.1093/neuonc/noaf201.1012

2025-11-010
OAAI